| 1 | prague czech republic | | | | | | | 3 | 0.63% |
| 2 | czech republic chemoprojekt | | | | | | | 2 | 0.42% |
| 3 | safichem group ag tödistrasse | | | | | | | 2 | 0.42% |
| 4 | group ag tödistrasse 16 | | | | | | | 2 | 0.42% |
| 5 | new technologies and products | | | | | | | 2 | 0.42% |
| 6 | ag tödistrasse 16 8002 | | | | | | | 2 | 0.42% |
| 7 | plants research and development | | | | | | | 2 | 0.42% |
| 8 | power plants research and | | | | | | | 2 | 0.42% |
| 9 | czech republic 2021 | | | | | | | 2 | 0.42% |
| 10 | 2nd generation solar systems | | | | | | | 2 | 0.42% |
| 11 | biofuels 2nd generation solar | | | | | | | 2 | 0.42% |
| 12 | swiss confederation id number | | | | | | | 2 | 0.42% |
| 13 | promising new technologies and | | | | | | | 2 | 0.42% |
| 14 | confederation id number che105269567 | | | | | | | 2 | 0.42% |
| 15 | energy breweries distilleries manufacturing | | | | | | | 2 | 0.42% |
| 16 | water energy breweries distilleries | | | | | | | 2 | 0.42% |
| 17 | sources biofuels 2nd generation | | | | | | | 2 | 0.42% |
| 18 | research and development of | | | | | | | 2 | 0.42% |
| 19 | and integral part of | | | | | | | 1 | 0.21% |
| 20 | esg in complexity our focus | | | | | | | 1 | 0.21% |
| 21 | and products represent and | | | | | | | 1 | 0.21% |
| 22 | products represent and integral | | | | | | | 1 | 0.21% |
| 23 | represent and integral part | | | | | | | 1 | 0.21% |
| 24 | and esg in complexity our | | | | | | | 1 | 0.21% |
| 25 | business area gives full | | | | | | | 1 | 0.21% |
| 26 | the group each business | | | | | | | 1 | 0.21% |
| 27 | area gives full priority | | | | | | | 1 | 0.21% |
| 28 | environmental safety and esg in | | | | | | | 1 | 0.21% |
| 29 | priority to solutions of | | | | | | | 1 | 0.21% |
| 30 | group each business area | | | | | | | 1 | 0.21% |
| 31 | each business area gives | | | | | | | 1 | 0.21% |
| 32 | full priority to solutions | | | | | | | 1 | 0.21% |
| 33 | gives full priority to | | | | | | | 1 | 0.21% |
| 34 | safety and esg in complexity | | | | | | | 1 | 0.21% |
| 35 | safichem contact us | | | | | | | 1 | 0.21% |
| 36 | complexity our focus | | | | | | | 1 | 0.21% |
| 37 | of pharmaceuticals pharmaceutical industry | | | | | | | 1 | 0.21% |
| 38 | and development research and | | | | | | | 1 | 0.21% |
| 39 | research and development research | | | | | | | 1 | 0.21% |
| 40 | renewable sources biofuels 2nd | | | | | | | 1 | 0.21% |